Richard Harvey

Title: Richard Harvey: Innovator in Pediatric Leukemia Research

Introduction

Richard Harvey is a notable inventor based in Placitas, NM (US). He has made significant contributions to the field of pediatric oncology, particularly in the area of acute lymphoblastic leukemia (ALL). His work focuses on identifying genetic markers that can help in diagnosing and treating high-risk cases of B-precursor acute lymphoblastic leukemia.

Latest Patents

Richard Harvey holds a patent titled "Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same." This invention relates to the identification of genetic markers in patients with high-risk B-precursor acute lymphoblastic leukemia (B-ALL) and explores their relationship to therapeutic outcomes. The patent also encompasses diagnostic and prognostic methods utilizing these genetic markers, along with kits that provide microchips and/or immunoreagents for analyzing leukemia patients.

Career Highlights

Throughout his career, Richard has worked with esteemed organizations such as the University of New Mexico and Sandia Corporation. His experience in these institutions has allowed him to advance his research and contribute to the understanding of pediatric leukemia.

Collaborations

Richard has collaborated with notable colleagues, including Cheryl L. Willman and Susan R. Atlas. Their joint efforts have furthered research in the field and have had a positive impact on patient outcomes.

Conclusion

Richard Harvey's innovative work in identifying genetic markers for high-risk pediatric leukemia has the potential to transform diagnostic and therapeutic approaches in oncology. His contributions are invaluable to the medical community and offer hope for improved outcomes in affected patients.